谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Overall Survival (OS) Update: 2-Year Follow-Up from the Phase-3 RESORCE Trial of Regorafenib for Patients with Hepatocellular Carcinoma (HCC) Progressing on Sorafenib

D Waldschmidt,A Granito,P Merle,YH Huang,G Bodoky,O Yokosuka,O Rosmorduc,V Breder,R Gerolami,G Masi,PJ Ross, S Quinn,T Song,JP Bronowicki, I Olivier-Hourmand,M Kudo, MA LeBerre,A Baumhauer,G Meinhardt,G Han,J Bruix

Zeitschrift für Gastroenterologie（2019）

引用 0|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要